Table 6 Multivariable analysis of raleted factors associated with PIM and MRP

Age

1.002 (0.955–1.052)

0.935

0.988 (0.964–1.013)

0.344

1.024(0.966–1.086)

Gender (male)

0.810 (0.432–1.519)

0.511

1.448 (1.057–1.983)

0.021

1.035(0.499–2.150)

Department

 Cardiology

1.000

1.000

1.000

 Geriatrics

0.361 (0.101–1.283)

0.115

3.674 (2.089–6.459)

 < .001

0.668(0.121–3.683)

 Endocrinology

0.085 (0.029–0.247)

 < .001

1.323 (0.728–2.405)

0.358

0.068(0.020–0.230)

 Neurology

0.372 (0.132–1.052)

0.062

2.274 (1.451–3.566)

 < .001

0.477(0.146–1.566)

Health insurance

0.745 (0.271–2.046)

0.568

0.881 (0.529–1.467)

0.626

0.577(0.165–2.016)

Length of hospital stay

1.019 (0.940–1.106)

0.641

0.999 (0.961–1.038)

0.948

1.007(0.917–1.107)

CCI

1.114 (0.865–1.434)

0.403

0.961 (0.853–1.082)

0.511

1.193(0.868–1.639)

Number of diagnoses at discharge

0.970 (0.868–1.084)

0.589

1.016 (0.962–1.072)

0.578

1.007(0.881–1.150)

Number of drugs

 5–9

1.000

1.000

1.000

  ≥ 10

2.653 (1.275–5.522)

0.009

1.583 (1.114–2.248)

0.010

3.736(1.541–9.058)

Chronic conditions

 Hypertension

1.138 (0.568–2.278)

0.716

0.982 (0.672–1.435)

0.925

0.838(0.365–1.922)

 Type 2 diabetes

0.524 (0.237–1.158)

0.110

1.149 (0.800–1.649)

0.452

0.500(0.195–1.283)

 Coronary heart disease

3.002 (1.407–6.408)

0.004

1.141 (0.796–1.638)

0.472

2.620(1.090–6.297)

 Cerebral infarction

1.152 (0.562–2.359)

0.699

1.023 (0.713–1.468)

0.901

1.051(0.442–2.496)

 Hyperlipidemia

1.531 (0.793–2.958)

0.205

0.540 (0.386–0.756)

 < .001

1.400(0.651–3.013)